News
2h
News-Medical.Net on MSNShingles and RSV vaccines with AS01 adjuvant reduce dementia riskBy Hugo Francisco de Souza New research reveals that vaccines enhanced with the AS01 adjuvant may help shield the aging brain ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
She has since received the newer, more effective shingles vaccine, as well as a pneumonia shot, an RSV vaccine to guard against respiratory syncytial virus, annual flu shots and all recommended ...
Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...
The committee chair hinted at banning MMR shots for certain children, said Naomi Rogers, a science historian at Yale University.
A new CDC vaccine panel, handpicked by RFK Jr., released an updated list of recommended vaccines. However, only if the ...
U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...
A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...
A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...
The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...
Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results